THE EARLY TAVR TRIAL
Live / Registered — Registered (as of 30 Jan 2024)
What this means for you
Registered since 30 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90707216
- Registration number
- 7295094
- Mark type
- Design + words
- Filed
- 13 May 2021
- Published for opposition
- 08 Mar 2022
- Registered
- 30 Jan 2024
- Attorney of record
- Avraham Schwartz
Goods and services
- Class 042 — Scientific and technological services: Providing medical and scientific research information in the field of heart disease and clinical trials
Owner
- Edwards Lifesciences Corporation, Irvine, CA, US
- Edwards Lifesciences Corporation, Irvine, CA, US
- Edwards Lifesciences Corporation, Irvine, CA, US
Prosecution history
- 30 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 30 Jan 2024 — REGISTERED-PRINCIPAL REGISTER
- 29 Dec 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Dec 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 31 Oct 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Oct 2023 — USE AMENDMENT FILED
- 31 Oct 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Oct 2023 — TEAS STATEMENT OF USE RECEIVED
- 29 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Apr 2023 — SOU EXTENSION 2 GRANTED
- 27 Apr 2023 — SOU EXTENSION 2 FILED
- 27 Apr 2023 — SOU TEAS EXTENSION RECEIVED
- 26 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Oct 2022 — SOU EXTENSION 1 GRANTED
- 24 Oct 2022 — SOU EXTENSION 1 FILED